These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2433868)

  • 1. Topical application of potent glucocorticoids augments epidermal beta-adrenergic adenylate cyclase response in vivo.
    Kajita S; Iizuka H; Hirokawa M; Tsutsui M; Mizumoto T
    Acta Derm Venereol; 1986; 66(6):491-6. PubMed ID: 2433868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melittin-induced alteration of epidermal adenylate cyclase responses.
    Kajita S; Iizuka H
    Acta Derm Venereol; 1987; 67(4):295-300. PubMed ID: 2445146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new synthetic retinoid, E-5166, augments epidermal beta-adrenergic adenylate cyclase response.
    Iizuka H; Watanabe M; Ohkawara A
    Acta Derm Venereol; 1985; 65(6):459-64. PubMed ID: 2420107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 1,25-dihydroxyvitamin D3 on adenylate cyclase and protein kinase C in pig epidermis.
    Koizumi H; Yasui C; Ohkawara A
    Acta Derm Venereol; 1991; 71(1):6-10. PubMed ID: 1676219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultraviolet radiation augments epidermal beta-adrenergic adenylate cyclase response.
    Iizuka H; Kajita S; Ohkawara A
    J Invest Dermatol; 1985 May; 84(5):401-3. PubMed ID: 2987360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of UVB irradiation on epidermal adenylate cyclase responses in vitro: its relation to sunburn cell formation.
    Iizuka H; Ishida-Yamamoto A; Kajita S; Tsutsui M; Ohkuma N
    Arch Dermatol Res; 1988; 280(3):163-7. PubMed ID: 2897832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical PUVA treatment increases epidermal beta-adrenergic adenylate cyclase responsiveness.
    Kajita S; Iizuka H; Hashimoto Y; Ohkawara A
    Br J Dermatol; 1986 Apr; 114(4):413-8. PubMed ID: 2421755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency classification of topical corticosteroids: modern perspectives.
    Ashworth J
    Acta Derm Venereol Suppl (Stockh); 1989; 151():20-5; discussion 47-52. PubMed ID: 2696307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activators of protein kinase C but not of phospholipase C modulate adenylate cyclase-responses of normal pig epidermis.
    Iizuka H; Takahashi H; Ishida-Yamamoto A; Hashimoto Y
    Epithelial Cell Biol; 1995; 4(1):35-41. PubMed ID: 8563794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a multilamellar emulsion on glucocorticoid-induced epidermal atrophy and barrier impairment.
    Ahn SK; Bak HN; Park BD; Kim YH; Youm JK; Choi EH; Hong SP; Lee SH
    J Dermatol; 2006 Feb; 33(2):80-90. PubMed ID: 16556273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-induced modulation of the beta-adrenergic adenylate cyclase response of epidermis: its relation to epidermal phospholipase A2 activity.
    Iizuka H; Kajita S; Mizumoto T; Kawaguchi H
    J Invest Dermatol; 1986 Nov; 87(5):577-81. PubMed ID: 3021859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3':5'-monophosphate and potentiation of adenylate cyclase-activating agents.
    Marone G; Lichtenstein LM; Plaut M
    J Pharmacol Exp Ther; 1980 Nov; 215(2):469-78. PubMed ID: 6255128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
    Scarpace PJ; Abrass IB
    J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of glucocorticosteroids with enhanced ratio between topical and systemic effects.
    Thalén A; Brattsand R; Andersson PH
    Acta Derm Venereol Suppl (Stockh); 1989; 151():11-9; discussion 47-52. PubMed ID: 2624062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced alteration of beta-adrenergic adenylate cyclase response of epidermis.
    Ohkawara A; Iizuka H
    Arch Dermatol Res; 1985; 277(2):88-92. PubMed ID: 2985009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of calcipotriol and clobetasol-17-propionate on UVB-irradiated human skin: an immunohistochemical study.
    van der Vleuten CJ; Snijders CG; de Jong EM; van de Kerkhof PC
    Skin Pharmacol; 1996; 9(6):355-65. PubMed ID: 9055356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glucocorticoids on the beta-adrenergic adenylate cyclase system of pig skin.
    Iizuka H; Ohkawara A
    J Invest Dermatol; 1983 Jun; 80(6):524-8. PubMed ID: 6304200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent effect of topical corticosteroids on blood flow in human cutaneous tissue.
    Kristensen JK; Wadskov S; Henriksen O
    Acta Derm Venereol; 1978; 58(2):145-8. PubMed ID: 76394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.